Glossary · Treatments

Vaginal estrogen

Definition: Vaginal estrogen delivers low-dose estrogen directly to the vaginal and lower urinary tract tissues to treat genitourinary syndrome of menopause. Available as creams, tablets, inserts, and rings, it produces minimal systemic absorption — much lower than systemic HRT — making it suitable for many women who cannot take systemic estrogen.

Detailed definition

Vaginal estrogen products include estradiol cream (Estrace), conjugated equine estrogens cream (Premarin), estradiol vaginal tablets (Vagifem, Yuvafem), estradiol soft gel inserts (Imvexxy), and the estradiol vaginal ring (Estring). Doses are typically 10–25 mcg of estradiol per application several times weekly. Serum estradiol elevations from these doses are minimal — typically remaining within or only slightly above the postmenopausal baseline range. Treatment effects are local: restored vaginal epithelial thickness and glycogen, lowered vaginal pH, restored lactobacilli, improved lubrication, and reduced GSM symptoms within 6–12 weeks. Vaginal estrogen also reduces recurrent UTI frequency by roughly 50%. Multiple studies and the 2017 ACOG Committee Opinion conclude that low-dose vaginal estrogen is appropriate for many women who cannot use systemic HRT — including breast cancer survivors after consultation with their oncology team. Long-term safety data continue to support this position.

Why it matters in menopause

Vaginal estrogen is one of the most evidence-supported, low-risk treatments in menopause care, yet remains underused. Most postmenopausal women with GSM, dyspareunia, or recurrent UTIs are appropriate candidates. ClearedRx prescribes vaginal estrogen as a stand-alone therapy or alongside systemic HRT.

Sources

External references: Wikipedia.

← Back to full glossary